Abstract
The receptor for advanced glycation end products (RAGE) and its proinflammatory S100/calgranulin ligands are enriched in joints of subjects with rheumatoid arthritis (RA) and amplify the immune/inflammatory response. In a model of inflammatory arthritis, blockade of RAGE in mice immunized and challenged with bovine type II collagen suppressed clinical and histologic evidence of arthritis, in parallel with diminished levels of TNF-alpha, IL-6, and matrix metalloproteinases (MMP) 3, 9 and 13 in affected tissues. Allelic variation within key domains of RAGE may influence these proinflammatory mechanisms, thereby predisposing individuals to heightened inflammatory responses. A polymorphism of the RAGE gene within the ligand-binding domain of the receptor has been identified, consisting of a glycine to serine change at position 82. Cells bearing the RAGE 82S allele displayed enhanced binding and cytokine/MMP generation following ligation by a prototypic S100/calgranulin compared with cells expressing the RAGE 82G allele. In human subjects, a case-control study demonstrated an increased prevalence of the 82S allele in patients with RA compared with control subjects. These data suggest that RAGE 82S upregulates the inflammatory response upon engagement of S100/calgranulins, and, thereby, may contribute to enhanced proinflammatory mechanisms in immune/inflammatory diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hofmann MA, Drury S, Fu C et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 1999 97: 889–901
Chilosi M, Mombello A, Montagna L et al. Multimarker immunohistochemical staining of calgranulin, chloroacetate esterase, and S100 for simultaneous demonstration of inflammatory cells on paraffin sections J Histochem Cytochem 1990 38: 1669–1675
Youssef P, Roth J, Frosch MP et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane J Rheumatol 1990 26: 2523–2528
Frosch M, Strey A, Vogl T et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis Arthritis Rheum 2000 43: 628–637
Zimmer DB, Cornwall EH, Landar A, Song W . The S100 protein family: history, function, and expression Brain Res Bul 1995 37: 417–429
Schafer BW, Heinzmann CW . The S100 family of EF-hand calcium-binding proteins: functions and pathology TIBS 1996 21: 134–140
Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C . Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway J Biol Chem 1997 272: 9496–9502
Hudson BI, Stickland MH, Grant PJ . Identification of polymorphisms in the Receptor for Advanced Glycation End Products (RAGE) gene Diabetes 1998 47: 1155–1157
Prevost G, Fajardy I, Fontaine P, Danze PM, Besmond C . Human RAGE Gly82Ser dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes Eur J Immunogenet 1999 26: 343–348
Neeper M, Schmidt AM, Brett J et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 1992 267: 14998–15004
Schmidt AM, Vianna M, Gerlach M et al. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface J Biol Chem 1992 267: 14987–14997
Kislinger T, Fu C, Huber B et al. Nε carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation endproducts that activate cell signalling pathways and modulate gene expression J Biol Chem 1999 274: 31740–31749
Yan SD, Chen X, Fu J et al. RAGE and amyloid beta peptide neurotoxicity in Alzheimer’s disease Nature 1996 382: 685–691
Hori O, Brett J, Slattery T et al. The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and coexpression of RAGE and amphoterin in the developing nervous system J Biol Chem 1995 270: 25752–25761
Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B . Immunization against heterologous type II collagen induces arthritis in mice Nature 1980 283: 666–668
Trentham DE, Townes AS, Kang AH . Autoimmunity to type II collagen an experimental model of arthritis J Exp Med 1997 146: 857–868
Cathcart ES, Hayes KC, Gonnerman WA, Lazzari AA, Franzblau C . Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen Lab Invest 1986 54: 26–31
Park L, Raman KG, Lee KJ et al. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE) Nat Med 1998 4: 1025–1031
Quattrocchi E, Walmsley M, Browne K et al. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis J Immunol 1999 163: 1000–1009
Neurath MF, Hildner K, Becker C et al. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression Clin Exp Immunol 1999 115: 42–55
Pugin J, Widmer MC, Kosodo S, Liang CM, Preas HL II, Suffredini AF . Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators Am J Respir Cell Mol Biol 1999 20: 458–464
Lander HL, Tauras JM, Ogiste JS, Moss RA, Schmidt AM . Activation of the Receptor for Advanced Glycation Endproducts triggers a MAP Kinase pathway regulated by oxidant stress J Biol Chem 1997 272: 17810–17814
Taguchi A, Blood DC, del Toro GA et al. Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases Nature 2000 405: 354–360
Pisetsky DS . Tumor necrosis factor blockers in rheumatoid arthritis N Engl J Med 2000 342: 810–811
Boe A, Baiocchi M, Carbonatto M, Papoian R, Serlupi-Crescenzi O . Interleukin-6 knock-out mice are resistant to antigen-induced experimental arthritis Cytokine 1999 11: 1057–1064
Robak T, Gladalska A, Stepien H, Robak E . Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis Mediators Inflamm 1998 7: 347–353
Keyszer G, Lambiri I, Nagel R et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers J Rheumatol 1999 26: 251–258
Konttinen YT, Ainola M, Valleala H et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis Ann Rheum Dis 1999 58: 691–697
Iwaki-Egawa S, Watanabe Y, Matsuno H . Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis J Rheumatol 2001 28: 485–489
Kaneko O, Tomita T, Nakase T et al. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis Rheumatology 2001 40: 247–255
Meyer JM, Han J, Singh R, Moxley G . Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis Am J Hum Genet 1996 58: 371–383
Gregersen PK, Silver J, Winchester RJ . The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum 1987 30: 1205–1213
Stastny P . Association of the B-cell autoantigen DRW4 with rheumatoid arthritis N Engl J Med 1978 298: 869–871
Sugaya K, Fukagawa T, Matsumoto K et al. Three genes in the MHC Class III region near the junction with the class II: gene for Receptor of Advanced Glycosylation End Products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3 Genomics 1994 23: 408–419
Donato R . S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles Intl J Biochem Cell Biol 2001 33: 637–668
Lugering N, Stoll R, Schmid KW et al. The myeloic related protein MRP8/14 (27E10 antigen)-usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function Eur J Clin Invest 1995 25: 659–664
Schmid KW, Lugering N, Stoll R et al. Immunohistochemical demonstration of calcium-binding proteins MRP8 and MRP 14 and their heterodimer (27E10 antigen) in Crohn’s disease Human Pathol 1995 26: 334–337
Madsen P . Molecular cloning, occurrence and expression of a novel partially secreted protein ‘psoriasin’ that is highly up-regulated in psoriatic skin J Invest Dermatol 1991 97: 701–712
Gregersen PK . The North American Rheumatoid Arthritis Consortium – bringing genetic analysis to bear on disease susceptibility, severity and outcome Arthritis Care 1998 11: 1–2
Cornelis F, Faure S, Martinez M et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study Proc Natl Acad Sci USA 1998 95: 10746–10750
Weyand CM, Hicok KC, Conn DL, Goronzy JJ . The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis Ann Int Med 1992 117: 801–806
Eberhardt K, Fex E, Johnson U, Wollheim FA . Associations of HLA-DRB and -DQB genes with two and five year outcomes in rheumatoid arthritis Ann Rheum Dis 1996 55: 34–39
Reveille JD, Alarcon GS, Fowler SE et al. HLA-DRB1 genes and disease severity in rheumatoid arthritis Arthritis Rheum 1996 39: 1802–1807
Criswell LA, Mu H, Such CL, King MC . Inheritance of the shared epitope and long-term outcomes of rheumatoid arthritis among community-based Caucasian females Genet Epidemiol 1998 15: 61–72
Weyand CM, McCarthy TG, Goronzy JJ . Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis J Clin Invest 1995 95: 2120–2126
Hall FC, Weeks DE, Camillieri JP et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis QJM 1996 89: 821–829
Mattey DL, Hassell AB, Plant MJ et al. The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis Rheumatology (Oxford) 1999 38: 1221–1227
Seitz M, Perler M, Pichler W . Only weak association between disease severity and HLA-DRB1 genes in a Swiss population of rheumatoid arthritis patients Rheumatol Int 1996 16: 9–13
Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W . HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city-wide community based study J Rheumatol 1995 22: 2027–2033
Harrison B, Thomson W, Symmons D et al. The influence of HLA-DRB1 alleles and rheumatoid arthritis on disease outcome in an inception cohort of patients with early inflammatory arthritis Arthritis Rheum 1999 42: 2174–2183
Mulcahy B, Waldron-Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphtoxin region influences susceptibility to rheumatoid arthritis Am J Hum Genet 1996 59: 676–683
Ota M, Katsuyama Y, Kimura A et al. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region Genomics 2001 71: 263–270
Complete sequencing and gene map of a human major histocompatibility complex. The MHC sequencing consortium Nature 1999 401: 921–923
Hudson BI, Stickland MH, Futers TS, Grant PJ . Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy Diabetes 2001 50: 1505–1511
Lalla E, Lamster IB, Feit M et al. Blockade of RAGE suppresses periodontitis-associated alveolar bone loss in diabetic mice J Clin Invest 2000 105: 1117–1124
Kankova K, Zahejsky J, Marova I et al. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM J Diabetes Complications 2001 15: 185–192
Klotz I, Hunston D . Mathematical models for ligand-receptor binding J Biol Chem 1984 259: 10060–10062
Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988 31: 315–324
Svejgaard A, Ryder LP . HLA and disease associations: detecting the strongest association Tissue Antigens 1994 43: 18–27
Tiwari JL, Terasaki PI . The data and statistical analysis In: Tiwari JL, Terasaki PI (eds) HLA and Disease Associations Springer-Verlag: New York 1985 pp 18–22
Author information
Authors and Affiliations
Corresponding author
Additional information
This work is supported, in part, by the Surgical Research Fund of the College of Physicians & Surgeons, Columbia University, and by grants from the United States Public Health Service to DMS and AMS. Support for PKG and the North American Rheumatoid Arthritis Consortium (NARAC) is provided by the National Arthritis Foundation and by the United States Public Health Service. BIH, MHS and PJG gratefully acknowledge the assistance of Dr Mark S Shearman at Merck, Sharpe and Dohme. BIH is a junior research fellow of the British Heart Foundation (Junior Research Fellowship FS/2000007). MAH and LGB are postdoctoral research fellows of the Juvenile Diabetes Research Foundation. AMS is a recipient of a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.
Rights and permissions
About this article
Cite this article
Hofmann, M., Drury, S., Hudson, B. et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3, 123–135 (2002). https://doi.org/10.1038/sj.gene.6363861
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363861
Keywords
This article is cited by
-
Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies
Glycoconjugate Journal (2024)
-
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Molecular Medicine (2023)
-
The Association of HMGB1 and RAGE Gene Polymorphisms with IgA Vasculitis
Biochemical Genetics (2023)
-
Association between plasma sRAGE and emphysema according to the genotypes of AGER gene
BMC Pulmonary Medicine (2022)
-
RAGE is a Critical Mediator of Pulmonary Oxidative Stress, Alveolar Macrophage Activation and Emphysema in Response to Cigarette Smoke
Scientific Reports (2019)